The maturation of human gene therapy

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 11, 1996, Pages 1261-1265

  Friedmann, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene therapy; Public policy

Indexed keywords

FUTUROLOGY; GENE THERAPY; HUMAN; POLICY; PRIORITY JOURNAL; REVIEW; SCANDINAVIA;

EID: 0029800217     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb13908.x     Document Type: Review

References (37)

1. Friedmann T, Roblin R. Gene therapy for human genetic disease. Science 1972;175:949-55
2. Friedmann T. Gene therapy - an immature genie but certainly out of the bottle. Nature Med 1996;2:144-7
3. Brenner MK. Human somatic gene therapy: Progress and problems. J Intern Med 1995;237:229-39
4. Weatherall DJ. Scope and limitations of gene therapy. Br Med Bull 1995;51:1-11
5. Mulligan RC. The basic science of gene therapy. Science 1993; 260:926-32
6. Tabin CJ, Hoffmann JW, Goff SP, Weinberg RA. Adaptation of a retrovirus as a eucaryotic vector transmitting the herpes simplex thymidine kinase gene. Molec Cell Biol 1982;2:426-36
7. Wei C, Gibson M, Spear PG, Scolnick EM. Construction and isolation of a transmissible retrovirus containing the src gene from Harvey Murine Sarcoma Virus and the thymidine kinase gene from herpes simplex virus type I. J Virol 1981;39:935-44
8. Shimotohno K, Temin HM. Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell 1981;26:67-77
9. Willis RCW, Jolly DJ, Miller AD, et al. Partial phenotypic correction of human Lesch-Nyhan (hypoxanthine-guanine phosphoribosyltransferase-deficient) lymphoblasts with a transmissible retroviral vector. J Biol Chem 1984;259:7842-9
10. Kantoff PW, Kohn DB, Mitsuya H, et al. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1986; 83:6563-7
11. Friedmann T. Progress toward human gene therapy. Science 1989;244:1275-81
12. Cline MJ. Research on gene therapy. Basic Life Sci 1983;25:77-92
13. Fletcher JC, Moral problems and ethical issues in prospective human gene therapy. Virginia Law Rev 1983;69:515-46
14. Rosenberg SA, Aebersold P, Cornetta K, et al. Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990;323:570-8
15. Blaese RM. Development of gene therapy for immunodeficiency: Adenosine deaminase deficiency. Pediatr Res 1993;33 Suppl: S49-S55
16. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995;333:823-31
17. Bordignon C, Notarangelo LD, Nobili N, et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995;270:470-5
18. Blaese RM, Culver KW, Miller AD, et al. T lymphopcyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995;270:475-80
19. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's Muscular Dystrophy. N Engl J Med 1995;333:832-8
20. Varmus H. NIH review of gene therapy protocols. Science 1995;267:1889
21. Marshall E. Varmus orders up a review of the science of gene therapy. Science 1995;267:1588
22. Friedmann T. Pseudotyped retroviral vectors for studies of human gene therapy. Nature Med 1995;1:275-7
23. Chu T-HT, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol 1995;69:2659-63
24. Kasahara N, Dozy A, Kan YW. Targeting retroviral vectors to specific cells. Science 1995;269:417
25. Cosset F-L, Morling FJ, Takeuchi Y, Weiss RA, Collins MKL, Russell SJ. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995;69:6314-22
26. Martinez I, Dornburg R. Mapping of receptor binding domains in the envelope protein of spleen necrosis virus. J Virol 1995;69:4339-46
27. Naldini L, Blömer U, Gallay P, et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996;272:263-7
28. Bushman FD. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc Natl Acad Sci USA 1994;91:9233-7
29. Engelhardt JF, Ye X, Doranz B, Wilson JM. ABlation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994;91:6196-200
30. Armentano D, Sookdeo CC, Hehir KM, et al. Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum Gene Ther 1995;6:1343-53
31. + hematopoietic cells. BioTechniques 1995; 19:816-20
32. Deshane J, Siegal GP, Alvarez RD, et al. Targeted tumor killing via an intracellular antibody against erbB-2. J Clin Invest 1995; 96:2980-9
33. Wagner E, Zatloukal K, Cotten M, et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992;89:6099-103
34. Curiel D, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery Proc Natl Acad Sci USA 1991;88:8850-4
35. Rabinovsky ED, Ramchatesingh J, McManaman JL. Regulation of tyrosine hydroxylase gene expression in IMR-32 neuroblastoma cells by basic fibroblast growth factor and ciliary neurotrophic factor. J Neurochem 1995;64:2404-12
36. Raz E, Carson DA, Parker SE, et al. Intradermal gene immunization: The possible role of DNA uptake on the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994;91: 9519-23
37. Raz E, Watanabe A, Baird SM, et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993;90:4523-27